ADVERTISEMENT
LIVE DESK·Global markets desk·Last updated 14s ago
ADVERTISEMENT
Novara — A Smarter Way to Access Global Markets

Equities

Congressman Allen Shifts Focus to Semiconductors with Broadcom, TSMC Investments
EquitiesArticle

Congressman Allen Shifts Focus to Semiconductors with Broadcom, TSMC Investments

Richard W. Allen, Georgia’s representative, has reallocated capital toward semiconductor giants Broadcom and TSMC while divesting from Rollins Inc., reflecting industry sector preferences.

Priya Anand · 26 Sept 2026
Liberty Global shares slip to 52‑week low of $9.29 amid cost‑cut plan
EquitiesArticle

Liberty Global shares slip to 52‑week low of $9.29 amid cost‑cut plan

The stock fell 4.6% to $9.36 after hitting a yearly low, as the company confirmed 2026 guidance and announced £600m savings at Virgin Media O2.

Priya Anand · 26 Sept 2026
BlackRock MuniHoldings California Quality Fund drops to 52‑week low of $9.99
EquitiesArticle

BlackRock MuniHoldings California Quality Fund drops to 52‑week low of $9.99

The BlackRock MuniHoldings California Quality Fund (MUC) fell to a 52‑week low of $9.99, a 6.45% decline over the past year, while its dividend yield remains 6.35% after 29 years of payouts.

Priya Anand · 26 Sept 2026
Quadient Reports H1 2026: Digital Growth Drives Revenue, Lockers Sale to Improve Leverage
EquitiesArticle

Quadient Reports H1 2026: Digital Growth Drives Revenue, Lockers Sale to Improve Leverage

Quadient’s first-half 2026 results highlight strong digital expansion and a £65m sale of its UK lockers network, improving financial flexibility ahead of a broader divestment strategy.

Priya Anand · 26 Sept 2026
Palisade Bio’s ASCENTRA-UC PDE4 drug advances to Phase 2 with ulcerative colitis focus
EquitiesArticle

Palisade Bio’s ASCENTRA-UC PDE4 drug advances to Phase 2 with ulcerative colitis focus

Palisade Bio’s oral PDE4 inhibitor candidate PALI-2108 enters a Phase 2b trial for ulcerative colitis, following promising Phase I results and regulatory milestones.

Priya Anand · 26 Sept 2026
Hugo Boss Faces Scrutiny as Frasers Group Consolidates Control
EquitiesArticle

Hugo Boss Faces Scrutiny as Frasers Group Consolidates Control

British retailer Frasers Group raises stake to nearly 48% and gains a second board seat, increasing pressure on CEO Daniel Grieder to reverse the fashion brand's struggling share price.

Priya Anand · 26 Sept 2026
Nasdaq Expands Always-On Trading Vision Amid 2026 Commerce Symposium
EquitiesArticle

Nasdaq Expands Always-On Trading Vision Amid 2026 Commerce Symposium

Nasdaq outlines a $3B–$6B market opportunity by 2030 in trading, tokenization, and fintech, with strategic moves to extend market hours and digitize asset servicing.

Priya Anand · 26 Sept 2026
Meta, AMD, Akamai Lead Week’s Top Stock Movers with AI and Cloud Growth Catalysts
EquitiesArticle

Meta, AMD, Akamai Lead Week’s Top Stock Movers with AI and Cloud Growth Catalysts

Meta Platforms, Advanced Micro Devices, and Akamai Technologies drove gains amid AI-driven demand, while Moderna’s cancer vaccine progress and Oracle’s data center delays shaped market sentiment.

Priya Anand · 26 Sept 2026
FirstEnergy Corp. hits $43.72 low as 29-year dividend streak threatened
EquitiesArticle

FirstEnergy Corp. hits $43.72 low as 29-year dividend streak threatened

Stock falls 6.4% in six months amid revenue growth but earnings pressure

Priya Anand · 26 Sept 2026
ADVERTISEMENT
Vici Properties shares hit 52‑week low of $23.71
EquitiesArticle

Vici Properties shares hit 52‑week low of $23.71

The REIT fell to $23.71, down 25.5% over the past year, while posting Q2 revenue of $1.06 bn and launching a $1.75 bn notes offering.

Priya Anand · 26 Sept 2026
L.B. Foster reports rising margins, growth bets at Sidoti conference
EquitiesArticle

L.B. Foster reports rising margins, growth bets at Sidoti conference

L.B. Foster (FSTR) presented at the Sidoti & Company September 2026 Small-Cap Virtual Conference, highlighting improved margins and growth initiatives. The company reported a 390 basis point increase in adjusted EBITDA margin to 7.5% TTM, driven by portfolio changes and strategic investments.

Priya Anand · 26 Sept 2026
China’s AI exposure gap may force investors to target Chinese stocks
EquitiesArticle

China’s AI exposure gap may force investors to target Chinese stocks

A focus on China’s tech sector could offer emerging-market investors a way to capture AI-driven growth, despite recent declines in Chinese equities.

Priya Anand · 26 Sept 2026
Trump discloses up to $100k Strategy stock purchase in ethics filing
EquitiesArticle

Trump discloses up to $100k Strategy stock purchase in ethics filing

President Trump reported buying $50,001–$100,000 of Strategy shares in July, according to a US Office of Government Ethics filing, amid broader portfolio activity and administration crypto‑policy moves.

Priya Anand · 26 Sept 2026
Cava Group opens 500th restaurant in Minneapolis, expands to 30 states
EquitiesArticle

Cava Group opens 500th restaurant in Minneapolis, expands to 30 states

Cava Group Inc. opened its 500th fast‑casual outlet in Minneapolis, bringing its footprint to 30 states and the District of Columbia and targeting 1,000 locations by 2032.

Priya Anand · 26 Sept 2026
Okta CEO Sees Agentic AI as IAM’s Next Growth Frontier
EquitiesArticle

Okta CEO Sees Agentic AI as IAM’s Next Growth Frontier

Okta’s CEO projects a $100 billion-plus market for agentic identity management within five years, as the company bets on AI-driven security solutions.

Priya Anand · 26 Sept 2026
Gossamer Bio Submits First NDA for Seralutinib in Pulmonary Arterial Hypertension
EquitiesArticle

Gossamer Bio Submits First NDA for Seralutinib in Pulmonary Arterial Hypertension

The biotech's first new drug application to the FDA covers seralutinib for PAH, backed by a Phase 3 trial the agency called a 'filing issue' rather than a regulatory obstacle.

Priya Anand · 26 Sept 2026
IM Cannabis Regains Nasdaq Compliance After Maintaining $1 Share Price
EquitiesArticle

IM Cannabis Regains Nasdaq Compliance After Maintaining $1 Share Price

Shares of IM Cannabis Corp. held a closing bid price of at least $1 for 18 straight business days, satisfying Nasdaq's minimum bid requirement and resolving a listing deficiency.

Priya Anand · 26 Sept 2026
ATN International Declares $0.29 Quarterly Dividend, Payable Oct 9
EquitiesArticle

ATN International Declares $0.29 Quarterly Dividend, Payable Oct 9

The board of ATN International declared a quarterly cash dividend of $0.29 per share, with a record date of October 3 and payment scheduled for October 9. The company provides digital infrastructure and communications services in the United States and internationally, focusing on rural and remote markets.

Priya Anand · 26 Sept 2026
ADVERTISEMENT
ONE Nuclear completes SPAC merger, to trade as ONEN on Nasdaq
EquitiesArticle

ONE Nuclear completes SPAC merger, to trade as ONEN on Nasdaq

ONE Nuclear's business combination with Hennessy Capital Investment Corp. VII is complete, and the renamed firm will list on Nasdaq as ONEN, with trading expected to start Thursday.

Priya Anand · 26 Sept 2026
Cytek Biosciences Expands Digital Ecosystem with Cloud Analysis Tool
EquitiesArticle

Cytek Biosciences Expands Digital Ecosystem with Cloud Analysis Tool

Cytek Biosciences, Inc. (NASDAQ: CTKB) has launched a cloud-based analysis tool as part of its Cytek Cloud digital ecosystem, integrating the flow cytometry workflow from panel design to data analysis.

Priya Anand · 26 Sept 2026
Genco Shipping Boosts Dividends Amid Strong Q2 2026 Results
EquitiesArticle

Genco Shipping Boosts Dividends Amid Strong Q2 2026 Results

Genco Shipping & Trading (GNK) raised its dividend by over 400% in Q2 2026, guided to exceed $1.00 per share in 2026, and reported robust fleet performance and debt management.

Priya Anand · 26 Sept 2026
Global Industrial Raises Growth Plans at Small-Cap Virtual Conference
EquitiesArticle

Global Industrial Raises Growth Plans at Small-Cap Virtual Conference

CEO Anesa Chaibi outlines strategic shifts, including digital expansion and private-label expansion, amid revenue growth of 8.4% in H1 2026 and a 34% Canadian sales surge.

Priya Anand · 26 Sept 2026
Neovolta Q4 2026 Miss Drives Stock Drop Amid Strategic Shift
EquitiesArticle

Neovolta Q4 2026 Miss Drives Stock Drop Amid Strategic Shift

Neovolta’s earnings miss sparks after-hours decline as revenue and losses fall short of expectations, despite a strategic pivot toward commercial energy storage.

Priya Anand · 26 Sept 2026
Pacific Assets Trust shareholders approve liquidation scheme
EquitiesArticle

Pacific Assets Trust shareholders approve liquidation scheme

Shareholders of Pacific Assets Trust plc have approved a liquidation scheme, with 99.62% of votes cast in favor. The scheme involves the reclassification of shares and the appointment of joint liquidators.

Priya Anand · 26 Sept 2026
ADVERTISEMENT